Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Acquisitions (2024 - 2026)

Usana Health Sciences (USNA) has disclosed Acquisitions for 1 consecutive years, with $203.3 million as the latest value for Q4 2024.

  • On a quarterly basis, Acquisitions changed N/A to $203.3 million in Q4 2024 year-over-year; TTM through Sep 2025 was $203.3 million, a N/A change, with the full-year FY2024 number at $203.3 million, changed N/A from a year prior.
  • Acquisitions was $203.3 million for Q4 2024 at Usana Health Sciences.
  • In the past five years, Acquisitions ranged from a high of $203.3 million in Q4 2024 to a low of $203.3 million in Q4 2024.